Sarcoma

The approval of Halaven was based on an improvement in overall survival (OS) in a phase 3 study.

Based on this study, the monoclonal antibody is being investigated in an ongoing phase 3 study and has received an FDA Breakthrough Therapy Designation.

The approval is based on results from the phase 3 ET743-SAR-3007 trial.

Caregivers may grapple with practical and emotional challenges as they help loved ones manage cancer-related pain.

Treatment with eribulin mesylate significantly extended overall survival (OS) compared with dacarbazine in patients with advanced soft tissue sarcoma, according to topline results from a phase 3 clinical trial.

The Food and Drug Administration (FDA) granted a priority review to Yondelis to treat patients with the disease, including liposarcoma and leiomyosarcoma subtypes, who have previously received chemotherapy that included an anthracycline. The FDA will make its final approval decision within six months.

The Food and Drug Administration's calendar for making decisions on new cancer drugs and indications is taking shape for 2015, and the clock is ticking on at least 13 applications for novel agents and new therapeutic settings for existing drugs.

NORD was founded in 1983 by parents of children with rare diseases. Over the past 30 years, it has become a powerful advocacy voice for all patients with rare diseases, including cancer.

Goals and milestone recognitions may help children with cancer get through treatment a little easier.

Long-term and late effects from toxic regimens from childhood cancer treatments include heart damage, lung problems and infertility.

Pediatric cancer treatment has come a long way, but health problems persist in survivorship.

A recent report notes that certain health issues observed in young adult survivors are typically seen in much older individuals.

Sarcoma is more common in children and young adults.

Soft tissue sarcoma has benefited from research in other cancers.

Childhood and young adult cancer survivors need fertility preservation information, but are they getting it from their oncologists?

A kid can bring out the best in people.

Creating Hope for Childhood Cancer

Adolescent and young adult cancer survivors must be their own advocates to live long and well.

Online tool helps cancer survivors know what to look for years after treatment

Researchers found that in some childhood cancer survivors, a late effect called cardiomyopathy, a condition where the heart cannot pump properly, was tied to a specific gene and drug dose.

A report, published in the Journal of Clinical Oncology, looks at the outcomes in children and adolescents with cancer, hoping to provide insights that will guide future research.

Camp Friendship offers a week-long residential camp free of charge for kids with cancer.

The Childhood Cancer Foundation in Canada recognized the unique needs of teens with cancer and created Teen Connector, a Facebook-style website.

Kids with cancer, their siblings, and parents learn relaxation, meditation, and breathing techniques.

Parents can help ease the transition from school to clinic and back again.

There are several organizations and institutions that have prepared school-related documents and checklists for parents of childhood cancer patients.

Newer targets found on cancer cells are providing scientists the ammunition to better treat cancer.

Childhood cancer survivors need long-term surveillance to keep up with late-term effects, screenings, and other health-related issues.

Researchers identify what survivors need to get physically active.

Childhood cancer survivors find lifelong care at ACE program.